Denise Carter
2023
In 2023, Denise Carter earned a total compensation of $1.1M as Chief Operating Officer at Quoin Pharmaceuticals, Ltd., a 41% decrease compared to previous year.
Compensation breakdown
| Bonus | $240,900 |
|---|---|
| Option Awards | $292,266 |
| Salary | $481,800 |
| Other | $56,000 |
| Total | $1,070,966 |
Carter received $481.8K in salary, accounting for 45% of the total pay in 2023.
Carter also received $240.9K in bonus, $292.3K in option awards and $56K in other compensation.
Rankings
In 2023, Denise Carter's compensation ranked 1,125th out of 2,940 executives tracked by ExecPay. In other words, Carter earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,125 out of 2,940 | 62nd |
Division Manufacturing | 673 out of 1,622 | 59th |
Major group Chemicals And Allied Products | 453 out of 904 | 50th |
Industry group Drugs | 442 out of 867 | 49th |
Industry Pharmaceutical Preparations | 303 out of 625 | 52nd |
Source: SEC filing on October 24, 2024.
Carter's colleagues
We found two more compensation records of executives who worked with Denise Carter at Quoin Pharmaceuticals, Ltd. in 2023.